SUSurendra Uranw

Surendra Uranw

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Surendra Uranw has a total of 118 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Clinico-Epidemiological Characteristics, Hospital Care Interventions, and Clinical Outcomes of Patients with SARS-CoV-2 in Nepal: The Mediating Role of Age

    by Mamata Sharma Neupane, Hafizah Che Hassan, Surendra Uranw, Raj Kumar Mehta

    Coronavirus disease 2019 (COVID-19) outcomes among hospitalized patients are influenced by demographic characteristics, clinical presentation, and requirements for hospital-based care. Age is an important determinant of COVID-19 outcomes; however, its statistical role in the relationships between hospital-care interventions and survival has received limited attention in resource-constrained settings. This prospective observational analytical study assessed clinico-epidemiological characteristics, hospital-care interventions, clinical outcomes, and the mediating role of patient age group among adults hospitalized with SARS-CoV-2 infection in Nepal. A total of 348 adults with laboratory-confirmed SARS-CoV-2 infection were consecutively recruited at a tertiary care teaching hospital from March 30, 2022 to June 30, 2023 and followed until discharge or in-hospital death. Associations with survival were examined using Chi-square/Fisher’s exact tests and multivariable binary logistic regression. Mediation analyses were performed using Hayes’ PROCESS Macro version 4.2, Model 4, with 5,000 bias-corrected bootstrap samples. Of 348 participants, 277 (79.6%) survived and 71 (20.4%) died. Older adults constituted 41.1% of participants. Hypertension (29.3%) and diabetes mellitus (23.0%) were the most common comorbidities, while fever (81.0%), cough (75.9%), and dyspnea (48.0%) were the predominant symptoms. Age group and dyspnea remained independently associated with hospital survival in multivariable analysis. Steroid therapy, oxygen therapy, and respiratory support were significantly associated with survival in unadjusted analyses. Age group partially statistically mediated the steroid therapy–survival relationship (indirect effect = −0.1371; 95% bootstrap CI: −0.3053 to −0.0154), while the direct effect remained significant (c′ = −2.8670; p = 0.0049). No significant age-mediated indirect effects were observed for oxygen therapy or respiratory support. These findings highlight the importance of age and respiratory presentation in hospital outcomes and suggest age-related heterogeneity in the steroid therapy–survival relationship. The mediation finding should be interpreted as statistical rather than causal because age precedes treatment exposure.

  • Open Access

    Association of Laboratory Parameters with Clinical Outcomes of SARS-CoV-2 Patients

    by Mamata Sharma Neupane, Hafizah Che Hassan, Surendra Kumar Uranw, Raj Kumar Mehta

    Background: The COVID-19 pandemic has imposed a significant burden on healthcare systems, particularly in resource-limited settings. Laboratory biomarkers may help predict disease outcomes and guide clinical decisions. However, there is limited evidence from Nepal regarding the prognostic value of these markers among hospitalized COVID-19 patients.Methods: A hospital-based observational study was conducted among 348 RT-PCR–confirmed COVID-19 patients admitted to the COVID ICUs and wards of a tertiary care hospital in Nepal between March 2022 and June 2023. Data on sociodemographic characteristics, haematological parameters, liver and inflammatory markers, urine microscopy, and SARS-CoV-2 molecular gene markers were collected prospectively. Clinical outcomes were categorized as survived or died. Descriptive statistics, chi-square tests, and binary logistic regression were used to analyse associations and identify predictors of mortality.Results: Out of the total 348 patients included in the study, 71 patients (20.4%) died, while 277 patients (79.6%) survived. Among 348 patients, significant associations with mortality were observed for lymphopenia (p = .001), neutrophilia (p < .001), elevated ALT (p < .001), elevated AST (p = .001), and positive D-dimer (p < .001). High viral load (Ct value ?20) for E, N, and ORF1ab ab genes was also significantly associated with mortality in univariate analysis. Logistic regression identified D-dimer positivity (OR = 0.027, p = .001) and elevated ALT (OR = 0.356, p = .016) as independent predictors of mortality.Conclusions: Laboratory parameters, especially lymphocyte count, D-dimer, and ALT levels, are valuable prognostic indicators of clinical outcomes in hospitalized COVID-19 patients. Integrating these markers into clinical assessment may enhance early risk stratification and resource allocation.Keywords: Biomarkers; C-Reactive protein; COVID-19; critical care; d-dimer.

  • Open Access

    Comparison of self-collected vaginal swabs and first-void urine for detection of human papillomavirus in sexually active girls and women in three South Asian countries

    by Nigus Telele, Nishan Katuwal, Furqan Kabir, Sezanur Rahman, Sabin Bikram Shahi, Raja Ram Yadav, Fatima Aziz, Md Abir Hossain, Alexandra M. Hill, Indriana Permatasari, et al.

    Background: As more countries plan and launch human papillomavirus (HPV) vaccination campaigns, a variety of self-sampling methods and assays have been used for detecting high-risk HPV (HR-HPV) types. This study compared HR-HPV detection in self-collected vaginal swabs (SCVS) and first-void urine (FVU) among sexually active girls and women aged 15–25 years in diverse settings (Bangladesh, Nepal, and Pakistan) using harmonized methods for each step. Methods: Within the Global Burden Estimation of HPV (GLOBE-HPV) project, which aims to estimate HPV prevalence and incidence across eight low- and middle-income countries in South Asia and Sub-Saharan Africa, we analyzed paired SCVS and FVU samples from 753 participants in Bangladesh, Pakistan, and Nepal using standardized protocols. DNA was extracted using the QIAamp DNA Mini Kit, and HPV testing was performed with the Allplex HPV28 Detection PCR assay. We evaluated HPV detection and type-specific concordance using Cohen’s Kappa, McNemar’s test, and a 3 × 3 agreement table, along with accuracy and positive/negative agreement metrics. Results: The overall prevalence of 14 HR-HPV types was 8.6% in SCVS and 7.2% in FVU samples. Detection rates for 7 HR-HPV vaccine types were similar (5.3% in SCVS versus 5.0% in FVU), with nearly identical HPV 16/18 rates (2.3% in SCVS and 2.4% in FVU). Bi-directional type-specific discordance was noted, with each sample type detecting unique types. SCVS demonstrated higher sensitivity for detecting HPV types beyond the 9 vaccine types with McNemar p-values of 0.013 and 0.7). Samples with lower viral load (indicated by higher real-time PCR cycle threshold values) were more likely to yield discordant results. Conclusion: SCVS and FVU yielded similar HR-HPV results, including those targeted by the 9-valent HPV vaccine, in sexually active young women. Both non-invasive self-sampling methods have potential for use in large-scale HPV surveillance programs in resource-limited settings.

  • Dengue disease severity in humans is augmented by waning Japanese encephalitis virus immunity

    by Sidharth Malhotra, Birendra P. Gupta, Surendra Uranw, Chinmay Kumar Mantri, Abhay P.S. Rathore, Ashley L. St. John

    Owing to increased global movement, vector-spread permissive climate change, and increased vaccination coverage against certain flaviviruses, the likelihood of being exposed to multiple flaviviruses in a lifetime has increased. Although many Asian countries have routine vaccination campaigns against Japanese encephalitis virus (JEV), the effect of JEV immunity on dengue disease severity is largely unknown. Here, we aimed to understand the effect of preexisting immunity against JEV on subsequent dengue disease outcomes in a prospective human cohort in Nepal, which has a high prevalence of JEV immunity and rapidly rising dengue virus (DENV) infections. A cohort consisting of 546 participants was studied over three dengue seasons and 5 years. Chymase, a serum biomarker of severe dengue across multiple patient cohorts, was assessed alongside clinical outcomes to determine whether there were associations between JEV immunity and dengue severity. We observed that midrange neutralizing antibody titers, approximately a 1:160 serum dilution capable of inhibiting JEV, were associated with heightened biomarkers of dengue disease severity and warning signs of severe disease in this cohort of patients who were mostly experiencing primary dengue infections. These results suggest that waning immunity to JEV could enhance the severity of dengue disease. This highlights the potential of maintaining strong immunity to JEV through vaccine boosters, not only to maintain protection against JEV in endemic regions but also to limit the potential of antibody-mediated enhancement of dengue disease.


  • Open Access

    Unravelling the distribution of vectors of major vector-borne diseases in Koshi Province of Nepal: A concern of expansion in diverse geo-ecological and climatic regions

    by Lalita Roy, Surendra Uranw, Raja Ram Pote Shrestha

    Background: Vector-borne diseases, being major public health concerns, are either slated for elimination or projected for control in Nepal. One of the major challenges in controlling these VBDs is to halt their emergence and expansion in diverse geo-ecological and climatic regions. In this study, we collected vectors of major VBDs to understand their distribution, diversity, and association with ecological variances. Methodology/Principal findings: A descriptive cross-sectional survey was conducted to collect the vectors in five districts situated at altitudes of up to 98 – 1,274 meters in Koshi Province, Eastern Nepal, representing three distinct geo-ecological and climatic regions: mountain, hills and lowlands during May and June 2023. Adult vectors were captured using CDC miniature light traps, BG sentinel traps, and manual aspirators. Association of vectors’ abundance in function of the geo-ecological and climatic variables was assessed in two vector species ( Culex quinquefasciatus and Phlebotomus argentipes ). We found the malaria vector Anopheles annularis , the lymphatic filariasis vector Cu. quinquefasciatus and visceral leishmaniasis vector Ph. argentipes from all three geo-ecological regions. The other vectors of the malaria parasite, An. pseudowillmori and An. willmori , and Japanese encephalitis vector Cu. tritaeniorhynchus were recorded from hilly districts only. Mean temperature and rainfall had positive effect on Cu. quinquefasciatus density and deleterious on Ph. argentipes. Culex quinquefasciatus and Ph. argentipes were captured in high abundance per household in hills (IRR = 1.23 and IRR = 13.00, respectively) and mountain (IRR = 1.96 and IRR = 4.00, respectively) as compared to lowland. Conclusion: Two major vectors, Cu. quinquefasciatus and Ph. argentipes were indiscriminately present in all geo-ecological regions. Climatic variables favour vectors’ survival, distribution and growth in diverse altitudes, including areas previously impervious to the vectors and VBDs. Our findings alert the VBD control program and suggest regular monitoring, strengthening the existing surveillance system and evidence-based planning and implementation of vector control interventions in wider geo-ecological regions to prevent the disease transmission. Authors Summary: The Government of Nepal is committed to eliminate and control major vector-borne diseases: malaria, visceral leishmaniasis, lymphatic filariasis, Japanese encephalitis and dengue as a public health problem by 2030. These diseases, once endemic to lowlands with tropical and subtropical climates only, have been spread to a wide geography, including hills and mountains. These high-altitude areas were considered unsuitable for the existence of vectors and transmission of pathogens. Considering the impact of climate change on founding a favorable environment for the establishment of viable populations of vectors for pathogens transmission and thus threatening all the efforts of VBDs control and elimination, we conducted a cross-sectional survey to explore the diversity of vectors in varied geo-ecological regions. We collected vectors from five districts situated at different altitudes and having fairly diverse geography. Major vectors of responsible of transmission of pathogens causing VL and LF were abundantly present in all geo-ecological regions, while vectors of malarial parasites and dengue virus were sparsely present in fewer areas. This study also examined the feasibility of the integrated vector survey in favour of maximising the available resources for entomological investigations. Further, this study provides updated information on the diversity of the vectors in the areas having cases of VBDs and suggests authorities for regular monitoring, strengthening the existing surveillance system and evidence-based planning and implementation of vector control interventions to prevent the disease transmission in wider geo-ecological regions.

  • Open Access

    Visceral leishmaniasis in the hills of western Nepal: A transmission assessment

    by Surendra Uranw, Narayan Raj Bhattarai, Kristien Cloots, Lalita Roy, Keshav Rai, Usha Kiran, Uttam Raj Pyakurel, Bibek Kumar Lal, Sakib Burza, Suman Rijal, et al.

    In Nepal, visceral leishmaniasis (VL) has been targeted for elimination as a public health problem by 2026. Recently, increasing numbers of VL cases have been reported from districts of doubtful endemicity including hills and mountains, threatening the ongoing VL elimination program in Nepal. We conducted a multi-disciplinary, descriptive cross-sectional survey to assess the local transmission of Leishmania donovani in seven such districts situated at altitudes of up to 1,764 meters in western Nepal from March to December 2019. House-to-house surveys were performed for socio-demographic data and data on past and current VL cases. Venous blood was collected from all consenting individuals aged ≥2 years and tested with the rK39 RDT. Blood samples were also tested with direct agglutination test, and a titer of ≥1:1600 was taken as a marker of infection. A Leishmania donovani species-specific PCR (SSU-rDNA) was performed for parasite species confirmation. We also captured sand flies using CDC light traps and mouth aspirators. The house-to-house surveys documented 28 past and six new VL cases of which 82% (28/34) were without travel exposure. Overall, 4.1% (54/1320) of healthy participants tested positive for L. donovani on at least one serological or molecular test. Among asymptomatic individuals, 17% (9/54) were household contacts of past VL cases, compared to 0.5% (6/1266) among non-infected individuals. Phlebotomus argentipes, the vector of L. donovani, was found in all districts except in Bajura. L. donovani was confirmed in two asymptomatic individuals and one pool of sand flies of Phlebotomus (Adlerius) sp. We found epidemiological and entomological evidence for local transmission of L. donovani in areas previously considered as non-endemic for VL. The national VL elimination program should revise the endemicity status of these districts and extend surveillance and control activities to curb further transmission of the disease.


  • Open Access

    Using freeze-preventive cold boxes in rural Nepal: A study of equipment performance, acceptability, system fit, and cost

    by Sandeep Kumar, Pat Lennon, Surendra Uranw, Tessa Fielding, Mercy Mvundura, Adam Drolet, Steven Diesburg, Arindam Ray, Sagar Dahal, Bibek Lal, et al.


  • Open Access

    Source tracing of Leishmania donovani in emerging foci of visceral leishmaniasis in West Nepal

    by Pieter Monsieurs, Kristien Cloots, Surendra Uranw, Megha Raj Banjara, Prakash Ghimire, Sakib Burza, Epco Hasker, Jean-Claude Dujardin, Malgorzata Anna Domagalska

    We sequenced Leishmania donovani genomes in blood samples collected in emerging foci of Visceral Leishmaniasis, in West Nepal. We detected lineages which are very different from pre-elimination main parasite population: a new lineage and a rare one previously reported once in East Nepal. We highlight the need for genomic surveillance.

  • Open Access

    Exploring Shigella vaccine priorities and preferences: Results from a mixed-methods study in low- and middle-income settings

    by Jessica A. Fleming, Nikki Gurley, Sophia Knudson, Lassane Kabore, John Tanko Bawa, Patience Dapaah, Sandeep Kumar, Surendra Uranw, Thang Tran, Le Thi Phuong Mai, et al.


  • Open Access

    Good participatory practice for coronavirus disease 2019 (COVID-19) research: the case of a COVID-19 prevention study

    by Carlo Perrone, William Schilling, James J. Callery, Elizabeth A. Ashley, Mary Chambers, Hannah Chase, Piyush Dahal, Nipaphan Kanthawang, Supalert Nedsuwan, Borimas Hanboonkunupakarn, et al.

    Background: The COPCOV study (chloroquine/ hydroxychloroquine prevention of coronavirus disease), which started recruitment in April 2020, is a multi-country double-blind, randomised, placebo-controlled trial which is being conducted in healthcare facilities involved in COVID-19 case management. Participants are staff employed in facilities managing people with proven or suspected COVID-19. As part of the study, we conducted a series of engagement sessions. The aims were to assess the feasibility of the study, to identify context-specific ethical issues, to understand possible concerns, to fine tune research procedures and to refine the COPCOV information materials. Methods: The COPCOV study was approved by relevant institutional review boards. The sessions described in this paper were part of the study. We conducted a series of engagement sessions, each involving a short presentation of the study, a section where attendees were asked to express their willingness to participate in such a study, which information they would need to change their view and an open Q&A section. Answers were transcribed and coded into themes by two independent investigators. Themes were derived from the data. They complemented other site-specific engagement, communication, and public relation activities such as press releases and websites. Results and conclusions: From 16 th March 2020 to 20 th January 2021, 13 engagement sessions were conducted in Thailand, Laos, Vietnam, Nepal and the UK involving 222 attendees in total. Issues raised revolved around the social value and study rationale; safety of trial medications and risk-benefit balance; study design and commitments. These sessions helped us identify concerns people had, which helped us refine information materials as well as complement site feasibility assessments. Our experience strongly supports the use of participatory practices prior to conducting clinical trials.